News
ProVerum’s ProVee system could offer patients a safe and effective treatment without the need for highly invasive surgery.
ProVerum has raised $80 million in venture capital funding to complete the development of its minimally invasive, stent-like implant to relieve the urinary symptoms of an enlarged prostat | The Dublin ...
WEST COLUMBIA, S.C. — For older men, the symptoms of an enlarged prostate can be a real nuisance. Benign prostatic hyperplasia (BPH)—is a condition in men in which the prostate gland is ...
Common symptoms of enlarged prostate include frequent and urgent urination, trouble starting a urine stream, urinary retention, urinary incontinence and more. 2 Interestingly, the size of the ...
The 2016-founded Trinity College Dublin spin-out is behind ProVee, a minimally invasive solution for treating benign ...
Common symptoms of enlarged prostate include frequent and urgent urination, trouble starting a urine stream, urinary retention, urinary incontinence and more. 2 Interestingly, the size of the ...
When symptoms arise, Mulroy encourages men to schedule a medical exam to explore underlying causes and treatment options. It’s also important to discuss family history because genetics can be a risk ...
ProVerum announced today that it closed an $80 million Series B equity financing to support its benign prostatic hyperplasia ...
ProVerum Limited, the developer of the ProVee® System for BPH, a minimally invasive solution for treating benign prostatic hyperplasia (BPH), announced today the closing of an $80 million Series B ...
The sNDA is supported by data from the phase 3 URO-901-3005 study (ClinicalTrials.gov Identifier: NCT03902080), which included 1105 men with OAB symptoms receiving pharmacological therapy for BPH ...
At 3 months follow-up, the patient’s prostate volume dropped to 270 mL, his BPH symptoms were mild, and his quality of life score had improved from “terrible” to “pleased.” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results